Exclusive

Publication

Byline

Location

US Patent Issued to NINEBIOPHARM on April 21 for "Regentide-041 and composition comprising Regentide-041 for improving skin condition" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,595, issued on April 21, was assigned to NINEBIOPHARM Co. LTD. (Cheongju-si, South Korea). "Regentide-041 and composition comprising Regen... Read More


US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on April 21 for "Self-assembling insect ferritin nanoparticles" (District Of Columbia, Maryland, Tennessee, Pennsylvania, Georgia Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,596, issued on April 21, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Serv... Read More


US Patent Issued to Evaxion Biotech on April 21 for "Vaccines targeting Pseudomonas aeruginosa" (Danish Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,597, issued on April 21, was assigned to Evaxion Biotech A/S (Horsholm, Denmark). "Vaccines targeting Pseudomonas aeruginosa" was invented... Read More


US Patent Issued to Bactoclear Holdings on April 21 for "Chimeric klebicins" (Indian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,598, issued on April 21, was assigned to Bactoclear Holdings PTE Ltd. (Singapore). "Chimeric klebicins" was invented by Anisha Ambady (Ban... Read More


US Patent Issued to DANISCO US on April 21 for "Over-expression of GDS1 in yeast for increased ethanol and decreased acetate production" (California, Pennsylvania, Delaware Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,599, issued on April 21, was assigned to DANISCO US INC. (Palo Alto, Calif.). "Over-expression of GDS1 in yeast for increased ethanol and ... Read More


US Patent Issued to Donald Danforth Plant Science Center on April 21 for "Antimicrobial NCR2 peptides" (Missouri Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,600, issued on April 21, was assigned to Donald Danforth Plant Science Center (St. Louis). "Antimicrobial NCR2 peptides" was invented by D... Read More


US Patent Issued to Petroleo Brasileiro S.A.-Petrobras, Universidade Federal Do Ceara-UFC on April 21 for "Genetically modified microorganisms that carry out the heterologous production of modified versions of the surfactant protein LV-ranaspumin-1(LV-RSN-1), the modified versions of said surfactant protein, the synthetic genes encoding said surfactant protein, the expression cassettes containing said synthetic genes, and the expression vectors containing said synthetic genes" (Brazilian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,601, issued on April 21, was assigned to Petroleo Brasileiro S.A.-Petrobras (Rio de Janeiro, Brazil) and Universidade Federal Do Ceara-UFC ... Read More


US Patent Issued to OSLO UNIVERSITETSSYKEHUS HF on April 21 for "Recombinant CCN domain proteins and fusion proteins" (Norwegian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,602, issued on April 21, was assigned to OSLO UNIVERSITETSSYKEHUS HF (Nydalen, Norway). "Recombinant CCN domain proteins and fusion protei... Read More


US Patent Issued to Seattle Children's Hospital on April 21 for "IL-13 receptor alpha 2 targeted, zetakine directed T cell immunotherapy" (Washington Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,603, issued on April 21, was assigned to Seattle Children's Hospital (Seattle). "IL-13 receptor alpha 2 targeted, zetakine directed T cell... Read More


US Patent Issued to Regents of the University of Minnesota on April 21 for "Therapeutic compounds and methods" (Minnesota Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,604, issued on April 21, was assigned to Regents of the University of Minnesota (Minneapolis). "Therapeutic compounds and methods" was inv... Read More